| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5268859
Max Phase: Preclinical
Molecular Formula: C19H18ClFN4O4
Molecular Weight: 420.83
Associated Items:
Representations
Canonical SMILES: O[C@@H]1CO[C@H]2[C@@H]1OC[C@H]2Oc1nc2nc(NCc3ccccc3F)c(Cl)cc2[nH]1
Standard InChI: InChI=1S/C19H18ClFN4O4/c20-10-5-12-18(24-17(10)22-6-9-3-1-2-4-11(9)21)25-19(23-12)29-14-8-28-15-13(26)7-27-16(14)15/h1-5,13-16,26H,6-8H2,(H2,22,23,24,25)/t13-,14-,15-,16-/m1/s1
Standard InChI Key: AUGVTGBAHOUMQG-KLHDSHLOSA-N
Associated Targets(Human)
AMPK alpha2/beta2/gamma1 80 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 420.83 | Molecular Weight (Monoisotopic): 420.1001 | AlogP: 2.27 | #Rotatable Bonds: 5 |
| Polar Surface Area: 101.52 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.11 | CX Basic pKa: 0.69 | CX LogP: 2.54 | CX LogD: 2.54 |
| Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.58 | Np Likeness Score: -0.68 |
References
| 1. Tamura Y, Morita I, Hinata Y, Kojima E, Sasaki Y, Wada T, Asano M, Fujioka M, Hayasaki-Kajiwara Y, Iwasaki T, Matsumura K.. (2023) Identification of novel benzimidazole derivatives as highly potent AMPK activators with anti-diabetic profiles., 79 [PMID:36402454] [10.1016/j.bmcl.2022.129059] |
Source
Source(1):